Related Experiment Video
Updated: Aug 8, 2026

Generation of Human CD40-activated B cells
Published on: October 17, 2009
Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine
M Finney1, G R Guy, R H Michell
1Department of Immunology, Medical School, University of Birmingham, GB.
Insights
Interleukin-4 (IL4) initiates a novel signal transduction cascade in human B lymphocytes, involving calcium and cyclic adenosine monophosphate (cAMP) changes essential for CD23 expression. These findings differ significantly from those in murine B cells.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Interleukin-4 (IL4) is a key cytokine regulating B lymphocyte function.
- Understanding the precise molecular mechanisms of IL4 signaling is crucial for immunology and cell biology.
- Previous studies have highlighted differences in IL4 responses between human and murine B cells.
Purpose of the Study:
- To elucidate the novel signal transduction cascade initiated by IL4 in human tonsillar B lymphocytes.
- To identify the second messenger changes involved in IL4-mediated CD23 expression.
- To compare IL4 signaling pathways in human versus murine B cells.
Main Methods:
- Investigated second messenger changes including inositol 1,4,5-trisphosphate and Ca2+ levels.
- Measured cyclic adenosine monophosphate (cAMP) accumulation following IL4 stimulation.
- Assessed the role of these second messengers in the induction of CD23 expression.
Main Results:
- Human IL4 rapidly elevated inositol 1,4,5-trisphosphate and Ca2+ levels in B lymphocytes.
- A delayed, sustained increase in cAMP concentration was observed, dependent on Ca2+ and an unidentified IL4 signal.
- Both initial lipid hydrolysis products and delayed cAMP accumulation were critical for IL4-induced CD23 expression.
Conclusions:
- A novel IL4-initiated signal transduction cascade involving sequential second messenger changes was identified in human B lymphocytes.
- This cascade is essential for the IL4-driven upregulation of CD23, a key B cell activation marker.
- Significant differences exist in IL4 signaling pathways between human and murine B cells, warranting further investigation.
Abstract:
We report from three independent centers that, in human tonsillar B lymphocytes, human IL4 switches on a series of second messenger changes, the precise sequence of which constitutes a novel signal transduction cascade. It involves an immediate and transient elevation of inositol 1,4,5-trisphosphate and Ca2+ levels. This is followed several minutes later by a sustained rise in cellular cyclic adenosine monophosphate concentration, the triggering of which involves both the Ca2+ rise and an additional, as yet unidentified, IL4-generated signal. Both the products of the initial inositol lipid hydrolysis and the delayed cyclic adenosine monophosphate accumulation are essential for the later induction of CD23 expression, a major phenotypic change promoted in these cells by IL4. The striking contrast between these findings and those that have been observed for the IL4 triggering of murine B cells is discussed.
Related Concept Videos
Amplifying Signals via Second Messengers
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Cells of the Adaptive Immune Response
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

